b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30605220</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>21</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">2374-2445</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>5</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>May</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>JAMA oncology</Title>\n                <ISOAbbreviation>JAMA Oncol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>689-695</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaoncol.2018.5911</ELocationID>\n            <Abstract>\n                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">To date, there is no well-defined standard of care for early-stage pediatric Hodgkin lymphoma (HL), which may include chemotherapy alone or combined modality therapy (CMT) with chemotherapy followed by radiotherapy. Although the use of radiotherapy in pediatric HL is decreasing, this strategy remains controversial.</AbstractText>\n                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To examine the use of CMT in pediatric HL and its association with improved overall survival using data from a large cancer registry.</AbstractText>\n                <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This observational cohort study used data from the National Cancer Database to evaluate clinical features and survival outcomes among 5657 pediatric patients (age, 0.1-21 years) who received a diagnosis of stage I or II HL in the United States from January 1, 2004, to December 31, 2015. Statistical analysis was conducted from May 1 to November 1, 2018.</AbstractText>\n                <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Patients received definitive treatment with chemotherapy or CMT, defined as chemotherapy followed by radiotherapy.</AbstractText>\n                <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Kaplan-Meier survival curves were used to examine overall survival. The association between CMT use, covariables, and overall survival was assessed in multivariable Cox proportional hazards regression models. Use of radiotherapy was assessed over time.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among the 11\xe2\x80\xaf546 pediatric patients with HL in the National Cancer Database, 5657 patients (3004 females, 2596 males, and 57 missing information on sex; mean [SD] age, 17.1 [3.6] years) with stage I or II classic HL were analyzed. Of these patients, 2845 (50.3%) received CMT; use of CMT vs chemotherapy alone was associated with younger age (&lt;16 years, 1102 of 2845 [38.7%] vs 856 of 2812 [30.4%]; P\xe2\x80\x89&lt;\xe2\x80\x89.001), male sex (1369 of 2845 [48.1%] vs 1227 of 2812 [43.6%]; P\xe2\x80\x89&lt;\xe2\x80\x89.001), stage II disease (2467 of 2845 [86.7%] vs 2376 of 2812 [84.5%]; P\xe2\x80\x89=\xe2\x80\x89.02), and private health insurance (2065 of 2845 [72.6%] vs 1949 of 2812 [69.3%]; P\xe2\x80\x89=\xe2\x80\x89.002). The 5-year overall survival was 94.5% (confidence limits, 93.8%, 95.8%) for patients who received chemotherapy alone and 97.3% (confidence limits, 96.4%, 97.9%) for those who received CMT, which remained significant in the intention-to-treat analysis and multivariate analysis (adjusted hazard ratio for CMT, 0.57; 95% CI, 0.42-0.78; P\xe2\x80\x89&lt;\xe2\x80\x89.001). In the sensitivity analysis, the low-risk cohort (stage I-IIA) and adolescent and young adult patients had the greatest benefit from CMT (adjusted hazard ratio, 0.47; 95% CI, 0.40-0.56; P\xe2\x80\x89&lt;\xe2\x80\x89.001). The use of CMT decreased by 24.8% from 2004 to 2015 (from 59.7% [271 of 454] to 34.9% [153 of 438]).</AbstractText>\n                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">In this study, pediatric patients with early-stage HL receiving CMT experienced improved overall survival 5 years after treatment. There is a nationwide decrease in the use of CMT, perhaps reflecting the bias of ongoing clinical trials designed to avoid consolidation radiotherapy. This study represents the largest data set to date examining the role of CMT in pediatric HL.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Jhawar</LastName>\n                    <ForeName>Sachin R</ForeName>\n                    <Initials>SR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rivera-N\xc3\xba\xc3\xb1ez</LastName>\n                    <ForeName>Zorimar</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Biometrics Division, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biostatistics, Rutgers School of Public Health, New Brunswick, New Jersey.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Drachtman</LastName>\n                    <ForeName>Richard</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Section of Pediatric Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cole</LastName>\n                    <ForeName>Peter D</ForeName>\n                    <Initials>PD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Section of Pediatric Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hoppe</LastName>\n                    <ForeName>Bradford S</ForeName>\n                    <Initials>BS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, University of Florida, Gainesville.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>University of Florida Health Proton Therapy Institute, Jacksonville.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Parikh</LastName>\n                    <ForeName>Rahul R</ForeName>\n                    <Initials>RR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D064888">Observational Study</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>JAMA Oncol</MedlineTA>\n            <NlmUniqueID>101652861</NlmUniqueID>\n            <ISSNLinking>2374-2437</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):963-966</RefSource>\n                <PMID Version="1">31327424</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D059248" MajorTopicYN="N">Chemoradiotherapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006689" MajorTopicYN="N">Hodgkin Disease</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30605220</ArticleId>\n            <ArticleId IdType="pii">2719758</ArticleId>\n            <ArticleId IdType="doi">10.1001/jamaoncol.2018.5911</ArticleId>\n            <ArticleId IdType="pmc">PMC6512456</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>JAMA. 2012 Jun 27;307(24):2609-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22735430</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2017 Jun 1;35(16):1786-1794</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28291393</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Surg Oncol. 2008 Mar;15(3):683-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18183467</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2015 Oct;171(2):254-262</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26115355</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):619-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22251881</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):825-842</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28943076</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2015 Jun;169(5):647-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25824371</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Surg Oncol. 2004 Jan;85(1):1-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14696080</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2011 Feb 10;117(6):1806-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21037086</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Radiat Oncol. 1996 Jul;6(3):225-242</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10717180</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2007 Jan 20;25(3):332-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17235049</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Nov 10;28(32):4831-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20458029</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2018 Aug 1;124(15):3210-3219</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29738613</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Blood Cancer. 2017 Apr;64(4):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27786406</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2012 Sep 10;30(26):3174-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22649136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2002 Sep 15;20(18):3765-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12228196</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2015 Feb 20;33(6):625-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25584010</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pract Radiat Oncol. 2015 Mar-Apr;5(2):85-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25413415</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2000 Sep;85(9):3227-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10999813</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Blood Cancer. 2016 Sep;63(9):1522-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27149120</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2013 Feb 10;31(5):592-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23295809</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2006 Oct 12;355(15):1572-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17035650</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Aug 10;28(23):3680-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20625128</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2014 Nov 10;32(32):3651-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25311218</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leuk Lymphoma. 2013 Nov;54(11):2531-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23617324</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leuk Lymphoma. 2010 Dec;51(12):2198-207</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21054151</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2000 Apr;18(7):1500-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10735898</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2002 Jul 15;20(14):3081-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12118021</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leuk Lymphoma. 2012 Mar;53(3):354-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21812538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 1999 Dec;17(12):3736-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10577845</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1522-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21705151</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Blood Cancer. 2016 Mar;63(3):428-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26524117</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rev Bras Hematol Hemoter. 2012;34(1):48-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23049384</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):707-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27020112</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2013 Apr 20;31(12):1562-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23509321</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):684-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26279323</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22911615</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Haematologica. 2010 Mar;95(3):494-500</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19951972</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'